The Patent Medicines Industry in Georgian England Constructing the Market by the Potency of Print /

• Κύριος συγγραφέας: Mackintosh, Alan (Συγγραφέας, http://id.loc.gov/vocabulary/relators/aut)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Palgrave Macmillan, 2018.
• Έκδοση: 1st ed. 2018.
• Σειρά: Medicine and Biomedical Sciences in Modern History
• Θέματα: History.; Medicine-History.; Great Britain-History.; Law-History.; History of Science.; History of Medicine.; History of Britain and Ireland.; Legal History.

 In this book, the ownership, distribution and sale of patent medicines across Georgian England are explored for the first time, transforming our understanding of healthcare provision and the use of the printed word in that era. Patent medicines constituted a national industry which was largely popular, reputable and stable, not the visible manifestation of dishonest quackery as described later by doctors and many historians. Much of the distribution, promotion and sale of patent medicines was centrally controlled with directed advertising, specialisation, fixed prices and national procedures, and for the first time we can see the detailed working of a national market for a class of Georgian consumer goods. Furthermore, contemporaries were aware that changes in the consumers' 'imagination' increased the benefits of patent medicines above the effects of their pharmaceutical components. As the imagination was altered by the printed word, print can be considered as an essential ingredient of patent medicines. This book will challenge the assumptions of all those interested in the medical, business or print history of the period. 

 1. Introduction -- 2. The Status of Patent Medicines -- 3. Constructing the Industry -- 4. Connecting the Country -- 5. Supplying the Consumer -- 6. Persuading the Poorly -- 7. Utilising the Imagination as Therapy -- 8. Harnessing the Potency of Print -- 9. The Legacy of the Patent Medicines Industry.